Moolec Science SA Financials

Moolec Science SA (MLECW) reported $5.6M in total revenue for fiscal year 2024. This represents a 521.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Moolec Science SA (MLECW) revenue grew by 521.5% year-over-year, from $905K to $5.6M in fiscal year 2024.

No, Moolec Science SA (MLECW) reported a net income of -$7.3M in fiscal year 2024, with a net profit margin of -130.0%.

As of fiscal year 2024, Moolec Science SA (MLECW) had $5.4M in cash and equivalents against $249K in long-term debt.

Moolec Science SA (MLECW) had a net profit margin of -130.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Moolec Science SA (MLECW) has a return on equity of -107.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Moolec Science SA (MLECW) generated -$9.5M in free cash flow during fiscal year 2024. This represents a -26.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Moolec Science SA (MLECW) generated -$9.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Moolec Science SA (MLECW) had $34.8M in total assets as of fiscal year 2024, including both current and long-term assets.

Moolec Science SA (MLECW) invested $158K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Moolec Science SA (MLECW) had 38M shares outstanding as of fiscal year 2024.

Moolec Science SA (MLECW) had a current ratio of 1.69 as of fiscal year 2024, which is generally considered healthy.

Moolec Science SA (MLECW) had a debt-to-equity ratio of 0.04 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Moolec Science SA (MLECW) had a return on assets of -21.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2024 data, Moolec Science SA (MLECW) had $5.4M in cash against an annual operating cash burn of $9.3M. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Moolec Science SA (MLECW) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Moolec Science SA (MLECW) has an earnings quality ratio of 1.28x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.